ID

41558

Description

3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial; ODM derived from: https://clinicaltrials.gov/show/NCT01563354 according to the information on clinicaltrials.gov "other protocol-defined inclusion/exclusion-criteria may apply"

Link

https://clinicaltrials.gov/show/NCT01563354

Keywords

  1. 11/10/20 11/10/20 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

November 10, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Neuroendocrine Carcinoma of the Lung and Thymus NCT01563354

Eligibility Neuroendocrine Carcinoma of the Lung and Thymus NCT01563354

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histological confirmed advanced well differentiated typical and atypical carcinoid tumors of the lung or thymus
Description

histological confirmed advanced well differentiated carcinoid tumors of the lung or thymus

Data type

boolean

Alias
UMLS CUI [1,1]
C0449575
UMLS CUI [1,2]
C0205615
UMLS CUI [1,3]
C0280089
UMLS CUI [1,4]
C0205179
UMLS CUI [2,1]
C0449575
UMLS CUI [2,2]
C0205615
UMLS CUI [2,3]
C0007095
UMLS CUI [2,4]
C0040113
UMLS CUI [2,5]
C0205179
patients of all treatment lines including naive patients can be enrolled
Description

patients of all treatment lines including naive patients

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2200127
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0206695
UMLS CUI [2,3]
C0040113
UMLS CUI [3,1]
C0332155
UMLS CUI [3,2]
C2200127
UMLS CUI [4,1]
C0332155
UMLS CUI [4,2]
C0206695
UMLS CUI [4,3]
C0040113
at least one measurable lesion of disease on ct scan or mri
Description

at least one measurable lesion of disease on ct scan or mri

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
UMLS CUI [1,3]
C2200127
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0024485
UMLS CUI [2,3]
C2200127
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C0040405
UMLS CUI [3,3]
C0206695
UMLS CUI [3,4]
C0040113
UMLS CUI [4,1]
C1513041
UMLS CUI [4,2]
C0024485
UMLS CUI [4,3]
C0206695
UMLS CUI [4,4]
C0040113
radiological documentation of disease progression within 12 months prior to randomization
Description

radiological documentation of disease progression prior to randomization

Data type

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C1290916
UMLS CUI [1,3]
C0242656
adequate liver, renal and bone marrow function
Description

adequate liver, renal and bone marrow function

Data type

boolean

Alias
UMLS CUI [1,1]
C0205410
UMLS CUI [1,2]
C0232741
UMLS CUI [2,1]
C0205410
UMLS CUI [2,2]
C0232804
UMLS CUI [3,1]
C0205410
UMLS CUI [3,2]
C0005953
UMLS CUI [3,3]
C0678852
who performance status 0-2
Description

who performance status

Data type

boolean

Alias
UMLS CUI [1]
C1298650
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
poorly differentiated neuroendocrine carcinoma
Description

poorly differentiated neuroendocrine carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0205617
UMLS CUI [1,2]
C0206695
non-neuroendocrine thymoma
Description

non-neuroendocrine thymoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0040100
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0206695
patients with severe functional disease requiring symptomatic treatment with somatostatin analogs
Description

patients with severe functional disease requiring treatment with somatostatin analogs

Data type

boolean

Alias
UMLS CUI [1,1]
C0277785
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C1514873
UMLS CUI [1,4]
C0732165
prior therapy with mtor inhibitors
Description

prior therapy with mtor inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C2746052
history of liver disease
Description

history of liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0023895
baseline qtcf> 470 msec
Description

baseline qtcf

Data type

boolean

Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C1882513
uncontrolled diabetes mellitus despite adequate therapy
Description

uncontrolled diabetes mellitus despite adequate therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0205411

Similar models

Eligibility Neuroendocrine Carcinoma of the Lung and Thymus NCT01563354

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
histological confirmed advanced well differentiated carcinoid tumors of the lung or thymus
Item
histological confirmed advanced well differentiated typical and atypical carcinoid tumors of the lung or thymus
boolean
C0449575 (UMLS CUI [1,1])
C0205615 (UMLS CUI [1,2])
C0280089 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,4])
C0449575 (UMLS CUI [2,1])
C0205615 (UMLS CUI [2,2])
C0007095 (UMLS CUI [2,3])
C0040113 (UMLS CUI [2,4])
C0205179 (UMLS CUI [2,5])
patients of all treatment lines including naive patients
Item
patients of all treatment lines including naive patients can be enrolled
boolean
C0087111 (UMLS CUI [1,1])
C2200127 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0206695 (UMLS CUI [2,2])
C0040113 (UMLS CUI [2,3])
C0332155 (UMLS CUI [3,1])
C2200127 (UMLS CUI [3,2])
C0332155 (UMLS CUI [4,1])
C0206695 (UMLS CUI [4,2])
C0040113 (UMLS CUI [4,3])
at least one measurable lesion of disease on ct scan or mri
Item
at least one measurable lesion of disease on ct scan or mri
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C2200127 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C2200127 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C0040405 (UMLS CUI [3,2])
C0206695 (UMLS CUI [3,3])
C0040113 (UMLS CUI [3,4])
C1513041 (UMLS CUI [4,1])
C0024485 (UMLS CUI [4,2])
C0206695 (UMLS CUI [4,3])
C0040113 (UMLS CUI [4,4])
radiological documentation of disease progression prior to randomization
Item
radiological documentation of disease progression within 12 months prior to randomization
boolean
C0332185 (UMLS CUI [1,1])
C1290916 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,3])
adequate liver, renal and bone marrow function
Item
adequate liver, renal and bone marrow function
boolean
C0205410 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0205410 (UMLS CUI [2,1])
C0232804 (UMLS CUI [2,2])
C0205410 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C0678852 (UMLS CUI [3,3])
who performance status
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
poorly differentiated neuroendocrine carcinoma
Item
poorly differentiated neuroendocrine carcinoma
boolean
C0205617 (UMLS CUI [1,1])
C0206695 (UMLS CUI [1,2])
non-neuroendocrine thymoma
Item
non-neuroendocrine thymoma
boolean
C0040100 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0206695 (UMLS CUI [1,3])
patients with severe functional disease requiring treatment with somatostatin analogs
Item
patients with severe functional disease requiring symptomatic treatment with somatostatin analogs
boolean
C0277785 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0732165 (UMLS CUI [1,4])
prior therapy with mtor inhibitors
Item
prior therapy with mtor inhibitors
boolean
C1514463 (UMLS CUI [1,1])
C2746052 (UMLS CUI [1,2])
history of liver disease
Item
history of liver disease
boolean
C0262926 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
baseline qtcf
Item
baseline qtcf> 470 msec
boolean
C1442488 (UMLS CUI [1,1])
C1882513 (UMLS CUI [1,2])
uncontrolled diabetes mellitus despite adequate therapy
Item
uncontrolled diabetes mellitus despite adequate therapy
boolean
C0011849 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0205411 (UMLS CUI [1,4])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial